Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376:254–66.

Article  PubMed  CAS  Google Scholar 

Nyberg ST, Batty GD, Pentti J, Virtanen M, Alfredsson L, Fransson EI, et al. Obesity and loss of disease-free years owing to major non-communicable diseases: a multicohort study. Lancet Public Health. 2018;3:e490–e7.

Article  PubMed  PubMed Central  Google Scholar 

Limpijankit T, Vathesatogkit P, Matchariyakul D, Wiriyatanakorn S, Siriyotha S, Thakkinstian A, et al. Causal relationship of excess body weight on cardiovascular events through risk factors. Sci Rep. 2022;12:5269.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer — viewpoint of the IARC working group. N Engl J Med. 2016;375:794–8.

Article  PubMed  PubMed Central  Google Scholar 

Waters H, Graf M. America’s Obesity Crisis: The Health and Economic Costs of Excess Weight. Milken Institute; 2018.

Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, et al. Projected U.S. State-level prevalence of adult obesity and severe obesity. N. Engl J Med. 2019;381:2440–50.

Article  PubMed  Google Scholar 

Acosta A, Streett S, Kroh MD, Cheskin LJ, Saunders KH, Kurian M, et al. White paper AGA: POWER - practice guide on obesity and weight management, education, and resources. Clin Gastroenterol Hepatol. 2017;15:631–49.e10.

Article  PubMed  Google Scholar 

Wing RR, Lang W, Wadden TA, Safford M, Knowler WC, Bertoni AG, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34:1481–6.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Brown JD, Buscemi J, Milsom V, Malcolm R, O’Neil PM. Effects on cardiovascular risk factors of weight losses limited to 5-10. Transl Behav Med. 2016;6:339–46.

Article  PubMed  Google Scholar 

Wadden TA, West DS, Delahanty L, Jakicic J, Rejeski J, Williamson D, et al. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity. 2006;14:737–52.

Article  PubMed  Google Scholar 

The Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54.

Article  PubMed Central  Google Scholar 

The Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity. 2014;22:5–13.

Article  Google Scholar 

Wharton S, Lau DCW, Vallis M, Sharma AM, Biertho L, Campbell-Scherer D, et al. Obesity in adults: a clinical practice guideline. Cmaj. 2020;192:E875–e91.

Article  PubMed  PubMed Central  Google Scholar 

McCarty TR, Thompson CC. The current state of bariatric endoscopy. Dig Endosc. 2021;33:321–34.

Article  PubMed  Google Scholar 

Carlsson LMS, Sjöholm K, Jacobson P, Andersson-Assarsson JC, Svensson P-A, Taube M, et al. Life expectancy after bariatric surgery in the Swedish obese subjects study. N Engl J Med. 2020;383:1535–43.

Article  PubMed  PubMed Central  Google Scholar 

Alvarez R, Bonham AJ, Buda CM, Carlin AM, Ghaferi AA, Varban OA. Factors associated with long wait times for bariatric surgery. Ann Surg. 2019;270:1103–9.

Article  PubMed  Google Scholar 

Rocha-González HI, De la Cruz-Álvarez LE, Kammar-García A, Canizales-Quinteros S, Huerta-Cruz JC, Barranco-Garduño LM, et al. Weight loss at first month and development of tolerance as possible predictors of 30 mg phentermine efficacy at 6 months. J Pers Med. 2021;11:1354.

Article  PubMed  PubMed Central  Google Scholar 

Kim KK, Cho HJ, Kang HC, Youn BB, Lee KR. Effects on weight reduction and safety of short-term phentermine administration in Korean obese people. Yonsei Med J. 2006;47:614–25.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Müller TD, Blüher M, Tschöp MH, DiMarchi RD. Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov. 2022;21:201–23.

Article  PubMed  Google Scholar 

Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989–1002.

Article  PubMed  CAS  Google Scholar 

Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387:205–16.

Article  PubMed  CAS  Google Scholar 

Volpe S, Lisco G, Fanelli M, Racaniello D, Colaianni V, Triggiani D, et al. Once-weekly subcutaneous semaglutide improves fatty liver disease in patients with type 2 diabetes: a 52-week prospective real-life study. Nutrients. 2022;14:4673.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lincoff AM, Brown-Frandsen K, Colhoun HM, Deanfield J, Emerson SS, Esbjerg S, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389:2221–32.

Article  PubMed  CAS  Google Scholar 

Lu Y, Liu Y, Krumholz HM. Racial and ethnic disparities in financial barriers among overweight and obese adults eligible for semaglutide in the United States. J Am Heart Assoc. 2022;11:e025545.

Article  PubMed  PubMed Central  Google Scholar 

Cifuentes L, Hurtado AM, Eckel-Passow J, Acosta A. Precision medicine for obesity. Dig Dis Inter. 2021;5:239–48.

Article  Google Scholar 

Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372:793–5.

Article  PubMed  PubMed Central  CAS  Google Scholar 

MacLean PS, Wing RR, Davidson T, Epstein L, Goodpaster B, Hall KD, et al. NIH working group report: Innovative research to improve maintenance of weight loss. Obesity. 2015;23:7–15.

Article  PubMed  Google Scholar 

MacLean PS, Rothman AJ, Nicastro HL, Czajkowski SM, Agurs-Collins T, Rice EL, et al. The Accumulating Data to Optimally Predict Obesity Treatment (ADOPT) core measures project: rationale and approach. Obesity. 2018;26:S6–s15.

Article  PubMed  Google Scholar 

Fujioka K, O'Neil PM, Davies M, Greenway F, C W Lau D, Claudius B, et al. Early weight loss with liraglutide 3.0 mg predicts 1-year weight loss and is associated with improvements in clinical markers. Obesity. 2016;24:2278–88.

Article  PubMed  CAS  Google Scholar 

Bhaskaran K, Dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6:944–53.

Article  PubMed  PubMed Central  Google Scholar 

Blundell J, de Graaf C, Hulshof T, Jebb S, Livingstone B, Lluch A, et al. Appetite control: methodological aspects of the evaluation of foods. Obes Rev. 2010;11:251–70.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sclafani A. Gut-brain nutrient signaling. Appetition vs. satiation. Appetite. 2013;71:454–8.

Article  PubMed  Google Scholar 

Lutter M, Nestler EJ. Homeostatic and hedonic signals interact in the regulation of food intake. J Nutr. 2009;139:629–32.

Article  PubMed  PubMed Central